www.fdanews.com/articles/126284-rexahn-reports-lsquo-compelling-rsquo-results-mdash-and-an-explanation
Rexahn Reports ‘Compelling’ Results — and an Explanation
April 16, 2010
Executives at Rexahn Pharmaceuticals envision a wide range of uses for its central nervous system drug Serdaxin, from biodefense to treating Alzheimer’s
disease.
Gazette
Gazette